Inactivation of SMAD4 tumor suppressor gene during gastric carcinoma progression

Clinical Cancer Research

Volumn 13, Issue 1, 2007, Pages 102-110

  Wang, Li Hui ^a,b   Kim, Seok Hyung ^c   Lee, Jung Hyun ^a   Choi, Yoon La ^d   Kim, Young Chul ^e   Park, Tae Sung ^c   Hong, Yun Chul ^f   Wu, Chun Fu ^b   Shin, Young Kee ^a,e  

^a Seoul National University   (South Korea)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^c Chungbuk National University College of Medicine   (South Korea)

^d Sungkyunkwan University School of Medicine   (South Korea)

^e Seoul National University   (South Korea)

^f Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; RNA; SMAD4 PROTEIN;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CANCER SURVIVAL; CELL LINE; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; EXON; FEMALE; GENE LOCUS; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METHYLATION; MULTIVARIATE ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STOMACH CARCINOMA;

AGED; AGED, 80 AND OVER; BASE SEQUENCE; CELL LINE, TUMOR; CELL NUCLEUS; CYTOPLASM; DISEASE PROGRESSION; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; PROTEASOME ENDOPEPTIDASE COMPLEX; SMAD4 PROTEIN; STOMACH NEOPLASMS;

EID: 33846326893     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-06-1467     Document Type: Article

References (42)

1. Hahn SA, Schutte M, Hoque AT, et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 1996;271:350-3.
2. Miyaki M, Kuroki T. Role of Smad4 (DPC4) inactivation in human cancer. Biochem Biophys Res Commun 2003;306:799-804.
3. Iacobuzio-Donahue CA, Song J, Parmiagiani G, et al. Missense mutation of MADH4: characterization of the mutational hot spot and functional consequences in human tumors. Clin Cancer Res 2004;10:1597-604.
4. Schutte M, Hruban RH, Hedrick L, et al. DPC4 gene in various tumor types. Cancer Res 1996;56:2527-30.
5. Kim SK, Fan Y, Papadimitrakopoulou V, et al. DPC4, a candidate tumor suppressor gene, is altered infrequently in head and neck squamous cell carcinoma. Cancer Res 1996;56:2519-21.
6. MacGrogan D, Pegram M, Slamon D, Bookstein R. Comparative mutational analysis of DPC4 (Smad4) in prostatic and colorectal carcinomas. Oncogene 1997;15:1111-4.
7. Lei J, Zou TT, Shi YQ, et al. Infrequent DPC4 gene mutation in esophageal cancer, gastric cancer and ulcerative colitis-associated neoplasms. Oncogene 1996; 13:2459-62.
8. Fukuchi M, Masuda N, Miyazaki T, et al. Decreased Smad4 expression in the transforming growth factor-β signaling pathway during progression of esophageal squamous cell carcinoma. Cancer 2002;95:737-43.
9. Horvath LG, Henshall SM, Kench JG, et al. Loss of BMP2, Smad8, and Smad4 expression in prostate cancer progression. Prostate 2004;59:234-42.
10. Miller DV, Leontovich AA, Lingle WL, et al. Utilizing Nottingham Prognostic Index in microarray gene expression profiling of breast carcinomas. Mod Pathol 2004;17:756-64.
11. Ramachandra M, Atencio I, Rahman A, et al. Restoration of transforming growth factor-β signaling by functional expression of smad4 induces anoikis. Cancer Res 2002;62:6045-51
12. Xiangming C, Natsugoe S, Takao S, et al. Preserved Smad4 expression in the transforming growth factor-β signaling pathway is a favorable prognostic factor in patients with advanced gastric cancer. Clin Cancer Res 2001;7:277-82.
13. Xie W, Bharathy S, Kim D, Haffty BG, Rimm DL, Reiss M. Frequent alterations of Smad signaling in human head and neck squamous cell carcinomas: a tissue microarray analysis. Oncol Res 2003;14:61-73.
14. Barbera VM, Martin M, Marinoso L, et al. The 18q21 region in colorectal and pancreatic cancer: independent loss of DCC and DPC4 expression. Biochim Biophys Acta 2000;1502:283-96.
15. Takaku K, Miyoshi H, Matsunaga A, Oshima M, Sasaki N, Taketo MM. Gastric and duodenal polyps in Smad4 (Dpc4) knockout mice. Cancer Res 1999;59:6113-7.
16. Xu X, Brodie SG, Yang X, et al. Haploid loss of the tumor suppressor Smad4/Dpc4 initiates gastric polyposis and cancer in mice. Oncogene 2000;19:1868-74.
17. Jones PA, Laird PW. Cancer epigenetics comes of age. Nat Genet 1999;21:163-7.
18. Roth S, Laiho P, Salovaara R, Launonen V, Aaltonen LA. No SMAD4 hypermethylation in colorectal cancer. Br J Cancer 2000;83:1015-9.
19. Minami R, Kitazawa R, Maeda S, Kitazawa S. Analysis of 5′-flanking region of human Smad4 (DPC4) gene. Biochim Biophys Acta 1998;1443:182-5.
20. Shi Y, Hata A, Lo RS, Massague J, Pavletich NP. A structural basis for mutational inactivation of the tumour suppressor Smad4. Nature 1997;388:87-93.
21. Wan M, Huang J, Jhala NC, et al. SCF(β-TrCP1) controls Smad4 protein stability in pancreatic cancer cells. Am J Pathol 2005;166:1379-92.
22. Liang M, Liang YY, Wrighton K, et al. Ubiquitination and proteolysis of cancer-derived Smad4 mutants by SCFSkp2. Mol Cell Biol 2004;24:7524-37.
23. Pierreux CE, Nicolas FJ, Hill CS. Transforming growth factor β-independent shuttling of Smad4 between the cytoplasm and nucleus. Mol Cell Biol 2000;20:9041-54.
24. Dong C, Li Z, Alvarez R, Jr., Feng XH, Goldschmidt-Clermont PJ. Microtubule binding to Smads may regulate TGF β activity. Mol Cell 2000;5:27-34.
25. Tang Y, Katuri V, Dillner A, Mishra B, Deng CX, Mishra L. Disruption of transforming growth factor-β signaling in ELF β-spectrin-deficient mice. Science 2003; 299:574-7.
26. Katuri V, Tang Y, Marshall B, et al. Inactivation of ELF/ TGF-β signaling in human gastrointestinal cancer. Oncogene 2005;24:8012-24.
27. Powell SM, Harper JC, Hamilton SR, Robinson CR, Cummings OW. Inactivation of Smad4 in gastric carcinomas. Cancer Res 1997;57:4221-4.
28. Wang LH, Choi YL, Hua XY, et al. Increased expression of sonic hedgehog and altered methylation of its promoter region in gastric cancer and its related lesions. Mod Pathol 2006;19:675-83.
29. Sinicrope FA, Ruan SB, Cleary KR, Stephens LC, Lee JJ, Levin B. bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res 1995;55:237-41.
30. Lee JY, Dong SM, Kim SY, Yoo NJ, Lee SH, Park WS. A simple, precise and economical microdissection technique for analysis of genomic DNA from archival tissue sections. Virchows Arch 1998;433:305-9.
31. Kitazawa S, Kitazawa R, Maeda S. Identification of methylated cytosine from archival formalin-fixed paraffin-embedded specimens. Lab Invest 2000;80:275-6.
32. Wang C, Horiuchi A, Imai T, et al. Expression of BRCA1 protein in benign, borderline, and malignant epithelial ovarian neoplasms and its relationship to methylation and allelic loss of the BRCA1 gene. J Pathol 2004;202:215-23.
33. Houlston R, Bevan S, Williams A, et al. Mutations in DPC4 (SMAD4) cause juvenile polyposis syndrome, but only account for a minority of cases. Hum Mol Genet 1998;7:1907-12.
34. Fan XM, Wong BC, Wang WP, et al. Inhibition of proteasome function induced apoptosis in gastric cancer, Int J Cancer 2001;93:481-8.
35. Ju HR, Jung U, Sonn CH, et al. Aberrant signaling of TGF-β1 by the mutant Smad4 in gastric cancer cells. Cancer Lett 2003;196:197-206.
36. Esteller M. Aberrant DNA methylation as a cancer-inducing mechanism. Annu Rev Pharmacol Toxicol 2005;45:629-56.
37. Esteller M, Corn PG, Baylin SB, Herman JG. A gene hypermethylation profile of human cancer. Cancer Res 2001;61:3225-9.
38. van Rees BP, Caspers E, zur Hausen A, et al. Different pattern of allelic loss in Epstein-Barr virus-positive gastric cancer with emphasis on the p53 tumor suppressor pathway. Am J Pathol 2002;161:1207-13.
39. Hollander GA, Zuklys S, Morel C, et al. Monoallelic expression of the interleukin-2 locus. Science 1998; 279:2118-21.
40. Fink SP, Mikkola D, Willson JK, Markowitz S. TGF-β-induced nuclear localization of Smad2 and Smad3 in Smad4 null cancer cell lines. Oncogene 2003;22:1317-23.
41. Reinacher-Schick A, Baldus SE, Romdhana B, et al. Loss of Smad4 correlates with loss of the invasion suppressor E-cadherin in advanced colorectal carcinomas. J Pathol 2004;202:412-20.
42. Muller N, Reinacher-Schick A, Baldus SE, et al. Smad4 induces the tumor suppressor E-cadherin and P-cadherin in colon carcinoma cells. Oncogene 2002; 21:6049-58.